치과용 마취 주사제 시장 규모, 점유율 및 동향 분석 보고서 : 제품 형태별, 연령층별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Dental Anesthesia Injectable Market Summary

The global dental anesthesia injectable market size was estimated at USD 1,452.3 million in 2025 and is projected to reach USD 2,494.5 million by 2033, growing at a CAGR of 7.0 % from 2026 to 2033. The growing prevalence of dental disorders such as tooth decay, periodontal diseases, and oral infections, which require pain management during procedures is attributed to market growth.

As populations age globally, the demand for dental treatments is also increasing, since older individuals are more prone to complex oral health issues that often involve surgical or restorative interventions requiring anesthesia.

In addition, contributing to market expansion is the increasing awareness of oral hygiene and the importance of preventive and corrective dental care. Governments and healthcare organizations are actively promoting dental health through public campaigns, leading to higher patient footfall in dental clinics. For instance, September 2025, the Department of Community Medicine, FOMS, KBN University conducted a National Oral Health Month Awareness Program on 30 September 2025 at an Anganwadi Centre to promote oral and hand hygiene among children and caregivers. The initiative included interactive demonstrations, educational sessions, and health check-ups to prevent common diseases. Such initiatives are expected to drive early diagnosis and treatment adoption, thereby supporting sustained growth in the dental healthcare market.

Anesthesia in dentistry is used to numb a specific area of the mouth, allowing procedures to be performed without pain while the patient remains conscious. According to the American Academy of Pediatric Dentistry, it involves the temporary loss of sensation in a targeted region using topical or injectable agents without affecting awareness. These anesthetics work by blocking nerve signals from reaching the brain, preventing pain while still allowing sensations like pressure. They typically act within minutes and last for about 30 to 60 minutes. Achieving numbness in the lower jaw can be more challenging than in the upper jaw due to anatomical differences. Dentists commonly use local anesthesia for procedures such as fillings, extractions, root canals, gum treatments, and crowns. Common agents include Lidocaine, articaine, prilocaine, mepivacaine, and bupivacaine, available in forms such as gels, sprays, and injections, depending on the procedure.

The increasing prevalence of dental conditions such as tooth decay, periodontal diseases, and impacted wisdom teeth, which often require extraction as a primary treatment. For instance, in the UK, from 2021 to 2024, total tooth extractions increased sharply from 22,549 to 49,112, more than doubling as dental services resumed after the disruption. Tooth decay extractions rose from 14,645 to 30,587, while non-tooth decay extractions increased from 7,904 to 18,525, indicating a strong recovery in both essential and elective procedures. The sustained rise in both essential and elective tooth extraction procedures is expected to continue driving strong demand for dental anesthesia injectables, thereby supporting the steady growth of this market over the forecast period.

Global Dental Anesthesia Injectable Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global dental anesthesia injectable market report based on product formulation, age group, application, end use, and region:

• Product Formulation Outlook (Revenue, USD Million, 2021 - 2033)
• Lidocaine 2% with Epinephrine
• Mepivacaine 2% with Epinephrine
• Mepivacaine 3% (Plain / Without Epinephrine)
• Articaine 4% with Epinephrine
• Bupivacaine 0.5% with Epinephrine
• Others (Prilocaine 4% with epinephrine, etc.)
• Age Group Outlook (Revenue, USD Million, 2021 - 2033)
• Pediatric (0-17 years)
• Adult (18-64 years)
• Geriatric (65+ years)
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Tooth Extraction
• Endodontic Procedures (Root Canal)
• Implantology
• Periodontal Surgery
• Restorative Dentistry & Minor Procedures
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Private Dental Clinics
• Hospitals & Maxillofacial Centers
• Public Health Institutions
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Product Formulation
  • 1.1.2. Age Group
  • 1.1.3. Application
  • 1.1.4. End Use
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Dental Anesthesia Injectable Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising prevalence of dental caries, periodontal diseases, and oral infections globally.
    • 3.2.1.2. Growing demand for painless and anxiety-free dental treatments.
    • 3.2.1.3. Expanding cosmetic dentistry procedures (veneers, whitening, implants).
    • 3.2.1.4. Aging population requires more restorative and surgical dental care.
    • 3.2.1.5. Advancements in anesthetic formulations (faster onset, longer duration).
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Risk of side effects such as allergic reactions and toxicity.
    • 3.2.2.2. Patient anxiety leads to avoidance of dental visits.
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Growth in pediatric dental anesthesia demands.
    • 3.2.3.2. Integration of AI and digital dentistry systems for precision anesthesia.
    • 3.2.3.3. Rising cosmetic dentistry demand among urban populations.
    • 3.2.3.4. Technological innovation in safety-engineered cartridge systems.
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. High competition from generic anesthetic products.
    • 3.2.4.2. Risk of adverse drug reactions affecting patient confidence.
• 3.3. Dental Anesthesia Injectable Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Dental Anesthesia Injectable Market: Product Formulation Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Dental Anesthesia Injectable Market: Product Formulation Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Global Dental Anesthesia Injectable Market Size & Trend Analysis, by Product Formulation, 2021 to 2033 (USD Million)
• 4.4. Lidocaine 2% with Epinephrine
  • 4.4.1. Lidocaine 2% with epinephrine market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Mepivacaine 2% with Epinephrine
  • 4.5.1. Mepivacaine 2% with epinephrine market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.6. Mepivacaine 3% (Plain / Without Epinephrine)
  • 4.6.1. Mepivacaine 3% (plain / without epinephrine) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.7. Articaine 4% with Epinephrine
  • 4.7.1. Articaine 4% with epinephrine market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.8. Bupivacaine 0.5% with Epinephrine
  • 4.8.1. Bupivacaine 0.5% with epinephrine market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.9. Others (Prilocaine 4% with epinephrine, etc.)
  • 4.9.1. Others (Prilocaine 4% with epinephrine, etc.) market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Dental Anesthesia Injectable Market: Age Group Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Dental Anesthesia Injectable Market: Age Group Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Global Dental Anesthesia Injectable Market Size & Trend Analysis, by Age Group 2021 to 2033 (USD Million)
• 5.4. Pediatric (0-17 years)
  • 5.4.1. Pediatric (0-17 years) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Adult (18-64 years)
  • 5.5.1. Adult (18-64 years) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Geriatric (65+ years)
  • 5.6.1. Geriatric (65+ years) market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Dental Anesthesia Injectable Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Dental Anesthesia Injectable Market: Application Movement Analysis, 2025 & 2033 (USD Million)
• 6.3. Global Dental Anesthesia Injectable Market Size & Trend Analysis, by Application 2021 to 2033 (USD Million)
• 6.4. Tooth Extraction
  • 6.4.1. Tooth extraction market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Endodontic Procedures (Root Canal)
  • 6.5.1. Endodontic procedures (root canal) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Implantology
  • 6.6.1. Implantology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Periodontal Surgery
  • 6.7.1. Periodontal surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.8. Restorative Dentistry & Minor Procedures
  • 6.8.1. Restorative dentistry & minor procedures market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Dental Anesthesia Injectable Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Dental Anesthesia Injectable Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
• 7.3. Global Dental Anesthesia Injectable Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Private Dental Clinics
  • 7.4.1. Private dental clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Hospitals & Maxillofacial Centers
  • 7.5.1. Hospitals & maxillofacial centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Public Health Institutions
  • 7.6.1. Public health institutions market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Dental Anesthesia Injectable Market: Regional Estimates & Trend Analysis by Product Formulation, Age Group, Application, and End Use

• 8.1. Regional Dashboard
• 8.2. Market Size and Trend Analysis, 2021 to 2033
• 8.3. North America
  • 8.3.1. North America dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory framework
    • 8.3.2.4. Reimbursement scenario
    • 8.3.2.5. U.S. dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory framework
    • 8.3.3.4. Reimbursement scenario
    • 8.3.3.5. Canada dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Competitive scenario
    • 8.3.4.3. Regulatory framework
    • 8.3.4.4. Reimbursement scenario
    • 8.3.4.5. Mexico dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Reimbursement scenario
    • 8.4.2.5. UK dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Reimbursement scenario
    • 8.4.3.5. Germany dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Reimbursement scenario
    • 8.4.4.5. France dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Competitive scenario
    • 8.4.5.3. Regulatory framework
    • 8.4.5.4. Reimbursement scenario
    • 8.4.5.5. Italy dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Competitive scenario
    • 8.4.6.3. Regulatory framework
    • 8.4.6.4. Reimbursement scenario
    • 8.4.6.5. Spain dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Competitive scenario
    • 8.4.7.3. Regulatory framework
    • 8.4.7.4. Reimbursement scenario
    • 8.4.7.5. Sweden dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Competitive scenario
    • 8.4.8.3. Regulatory framework
    • 8.4.8.4. Reimbursement scenario
    • 8.4.8.5. Denmark dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key country dynamics
    • 8.4.9.2. Competitive scenario
    • 8.4.9.3. Regulatory framework
    • 8.4.9.4. Reimbursement scenario
    • 8.4.9.5. Norway dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. China dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. Japan
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. Japan dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. India dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Reimbursement scenario
    • 8.5.5.5. South Korea dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Reimbursement scenario
    • 8.5.6.5. Australia dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Competitive scenario
    • 8.5.7.3. Regulatory framework
    • 8.5.7.4. Reimbursement scenario
    • 8.5.7.5. Thailand dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Brazil dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Reimbursement scenario
    • 8.6.3.5. Argentina dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.7. Middle East and Africa
  • 8.7.1. Middle East and Africa dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. South Africa dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. Saudi Arabia dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement scenario
    • 8.7.4.5. UAE dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Reimbursement scenario
    • 8.7.5.5. Kuwait dental anesthesia injectable market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis by Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Market Share Analysis, 2025
• 9.4. Company Heat Map Analysis
• 9.5. Strategy Mapping
  • 9.5.1. Expansion
  • 9.5.2. Mergers & Acquisition
  • 9.5.3. Partnerships & Collaborations
  • 9.5.4. New Technology Launches
  • 9.5.5. Research And Development
  • 9.5.6. Company Profiles
  • 9.5.7. Dentsply Sirona
    • 9.5.7.1. Company overview
    • 9.5.7.2. Financial performance
    • 9.5.7.3. Product Benchmarking
    • 9.5.7.4. Strategic initiatives
  • 9.5.8. Aspen Holdings
    • 9.5.8.1. Company overview
    • 9.5.8.2. Financial performance
    • 9.5.8.3. Product Benchmarking
    • 9.5.8.4. Strategic initiatives
  • 9.5.9. Septodont Holding
    • 9.5.9.1. Company overview
    • 9.5.9.2. Financial performance
    • 9.5.9.3. Product Benchmarking
    • 9.5.9.4. Strategic initiatives
  • 9.5.10. Fresenius Kabi USA
    • 9.5.10.1. Company overview
    • 9.5.10.2. Financial performance
    • 9.5.10.3. Product Benchmarking
    • 9.5.10.4. Strategic initiatives
  • 9.5.11. Centurion Healthcare
    • 9.5.11.1. Company overview
    • 9.5.11.2. Financial performance
    • 9.5.11.3. Product Benchmarking
    • 9.5.11.4. Strategic initiatives
  • 9.5.12. Pierrel
    • 9.5.12.1. Company overview
    • 9.5.12.2. Financial performance
    • 9.5.12.3. Product Benchmarking
    • 9.5.12.4. Strategic initiatives
  • 9.5.13. Huons
    • 9.5.13.1. Company overview
    • 9.5.13.2. Financial performance
    • 9.5.13.3. Product Benchmarking
    • 9.5.13.4. Strategic initiatives
  • 9.5.14. Zeyco
    • 9.5.14.1. Company overview
    • 9.5.14.2. Financial performance
    • 9.5.14.3. Product Benchmarking
    • 9.5.14.4. Strategic initiatives
  • 9.5.15. NEW STETIC S.A.
    • 9.5.15.1. Company overview
    • 9.5.15.2. Financial performance
    • 9.5.15.3. Product Benchmarking
    • 9.5.15.4. Strategic initiatives
  • 9.5.16. Acteon
    • 9.5.16.1. Company overview
    • 9.5.16.2. Financial performance
    • 9.5.16.3. Product Benchmarking
    • 9.5.16.4. Strategic initiatives
  • 9.5.17. Primex Pharmaceuticals
    • 9.5.17.1. Company overview
    • 9.5.17.2. Financial performance
    • 9.5.17.3. Product Benchmarking
    • 9.5.17.4. Strategic initiatives